These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8214956)

  • 1. Pseudomonas aeruginosa bronchopulmonary infection in late human immunodeficiency virus disease.
    Baron AD; Hollander H
    Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):992-6. PubMed ID: 8214956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudomonas aeruginosa infection in human immunodeficiency virus infected patients.
    Meynard JL; Barbut F; Guiguet M; Batisse D; Lalande V; Lesage D; Guiard-Schmid JB; Petit JC; Frottier J; Meyohas MC
    J Infect; 1999 May; 38(3):176-81. PubMed ID: 10424798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The spectrum of bronchopulmonary infection caused by Pseudomonas aeruginosa in patients infected with the human immunodeficiency virus].
    Santín Cerezales M; Aranda Sánchez M; Podzamczer Palter D; Maiques Llacer JM; Rufí Rigau G; Gudiol Munté F
    Rev Clin Esp; 1996 Oct; 196(10):692-7. PubMed ID: 9005472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomonas aeruginosa bronchopulmonary infection in patients with AIDS, with emphasis on relapsing infection.
    Domingo P; Ferré A; Baraldès MA; Ris J; Sánchez F
    Eur Respir J; 1998 Jul; 12(1):107-12. PubMed ID: 9701423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pseudomonas aeruginosa bacteremia in patients with HIV infection: clinicoepidemiologic study of 17 episodes].
    Salavert Lletí S; Navarro Ibáñez V; Roig Rico P; Bretón Martínez JR; Ponz Díez F; López Aldeguer J; Gobernado Serrano M
    Rev Clin Esp; 1996 Oct; 196(10):684-91. PubMed ID: 9005471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial Pseudomonas aeruginosa infection in patients with cystic fibrosis: characteristics of eradicated and persistent isolates.
    Tramper-Stranders GA; van der Ent CK; Molin S; Yang L; Hansen SK; Rau MH; Ciofu O; Johansen HK; Wolfs TF
    Clin Microbiol Infect; 2012 Jun; 18(6):567-74. PubMed ID: 21883670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Infection by Pseudomonas aeruginosa in patients with human immunodeficiency virus infection. Descriptive study of 35 cases].
    Elvira J; López-Suárez A; Clavo A; Piña JM; Segura E; Pérez-Guzmán E; Girón JA
    Enferm Infecc Microbiol Clin; 1998; 16(7):322-7. PubMed ID: 9808882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of pldA and exoU in mucoid Pseudomonas aeruginosa is associated with high risk of exacerbations in non-cystic fibrosis bronchiectasis patients.
    Luo RG; Miao XY; Luo LL; Mao B; Yu FY; Xu JF
    Clin Microbiol Infect; 2019 May; 25(5):601-606. PubMed ID: 30036669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features and outcome of patients with community-acquired Pseudomonas aeruginosa bacteraemia.
    Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
    Clin Microbiol Infect; 2005 May; 11(5):415-8. PubMed ID: 15819873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and determinants of Pseudomonas aeruginosa infection among persons with HIV: association with hospital exposure.
    Sorvillo F; Beall G; Turner PA; Beer VL; Kovacs AA; Kerndt PR
    Am J Infect Control; 2001 Apr; 29(2):79-84. PubMed ID: 11287873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical implications of ABO blood groups in Pseudomonas aeruginosa sepsis in children.
    Kuo KC; Kuo HC; Huang LT; Lin CS; Yang SN
    J Microbiol Immunol Infect; 2013 Apr; 46(2):109-14. PubMed ID: 22464692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community-acquired Pseudomonas aeruginosa urinary tract infections in children hospitalized in a tertiary center: relative frequency, risk factors, antimicrobial resistance and treatment.
    Marcus N; Ashkenazi S; Samra Z; Cohen A; Livni G
    Infection; 2008 Oct; 36(5):421-6. PubMed ID: 18795227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bronchopulmonary infection with Pseudomonas aeruginosa in patients infected with human immunodeficiency virus.
    Ali NJ; Kessel D; Miller RF
    Genitourin Med; 1995 Apr; 71(2):73-7. PubMed ID: 7744417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa bronchopulmonary infection in patients with advanced human immunodeficiency virus disease.
    Traill ZC; Miller RF; Ali N; Shaw PJ
    Br J Radiol; 1996 Dec; 69(828):1099-103. PubMed ID: 9135463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiology of community-acquired bacterial pneumonia in persons with and at risk for human immunodeficiency virus type 1 infection. Implications for rational empiric antibiotic therapy.
    Burack JH; Hahn JA; Saint-Maurice D; Jacobson MA
    Arch Intern Med; 1994 Nov; 154(22):2589-96. PubMed ID: 7979856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Geographical differences in first acquisition of Pseudomonas aeruginosa in cystic fibrosis.
    Ranganathan SC; Skoric B; Ramsay KA; Carzino R; Gibson AM; Hart E; Harrison J; Bell SC; Kidd TJ;
    Ann Am Thorac Soc; 2013 Apr; 10(2):108-14. PubMed ID: 23607838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serious Pseudomonas aeruginosa infection in AIDS.
    Shepp DH; Tang IT; Ramundo MB; Kaplan MK
    J Acquir Immune Defic Syndr (1988); 1994 Aug; 7(8):823-31. PubMed ID: 8021816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality prediction in pulmonary Mycobacterium kansasii infection and human immunodeficiency virus.
    Marras TK; Morris A; Gonzalez LC; Daley CL
    Am J Respir Crit Care Med; 2004 Oct; 170(7):793-8. PubMed ID: 15215152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudomonas aeruginosa bacteremia in patients infected with human immunodeficiency virus type 1.
    Vidal F; Mensa J; Martínez JA; Almela M; Marco F; Gatell JM; Richart C; Soriano E; Jiménez de Anta MT
    Eur J Clin Microbiol Infect Dis; 1999 Jul; 18(7):473-7. PubMed ID: 10482023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchoalveolar interleukin-1 beta: a marker of bacterial burden in mechanically ventilated patients with community-acquired pneumonia.
    Wu CL; Lee YL; Chang KM; Chang GC; King SL; Chiang CD; Niederman MS
    Crit Care Med; 2003 Mar; 31(3):812-7. PubMed ID: 12626989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.